U.S. senators will return to a prescription-drug safety bill on Monday and consider a drug importation measure that the pharmaceutical industry opposes and the White House has threatened to veto. The legislation is meant to bolster government oversight of prescription-drug side effects, and would also increase drug and medical devicemaker fees that help fund product reviews. But several senators want to attach amendments, including one that would allow Americans to legally import cheaper prescription drugs from Canada and other countries. FULL STORY
Senate weighs drug imports amid veto threat
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.